151 related articles for article (PubMed ID: 29746286)
1. Ranolazine for Symptomatic Management of Microvascular Angina.
Rayner-Hartley E; Parvand M; Humphries KH; Starovoytov A; Park JE; Sedlak T
Am J Ther; 2020; 27(2):e151-e158. PubMed ID: 29746286
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Coleman CI; Freemantle N; Kohn CG
BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine: Drug overview and possible role in primary microvascular angina management.
Cattaneo M; Porretta AP; Gallino A
Int J Cardiol; 2015 Feb; 181():376-81. PubMed ID: 25555283
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of ranolazine in the patient with microvascular angina, atrial fibrillation and migraine.
Osovska NY; Kuzminova NV
Wiad Lek; 2016; 69(6):832-837. PubMed ID: 28214825
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
Yuriivna Osovska N; Vitaliivna Kuzminova N
Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
8. Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study.
Pargaonkar VS; Tremmel JA; Schnittger I; Khandelwal A
Int J Cardiol; 2020 Jun; 309():8-13. PubMed ID: 32220488
[TBL] [Abstract][Full Text] [Related]
9. Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
Ahmed B; Mondragon J; Sheldon M; Clegg S
Cardiovasc Revasc Med; 2017 Sep; 18(6):431-435. PubMed ID: 28576663
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.
Mehta PK; Sharma S; Minissian M; Harsch MR; Martinson M; Nyman JA; Shaw LJ; Bairey Merz CN; Wenger NK
J Womens Health (Larchmt); 2019 May; 28(5):573-582. PubMed ID: 30888919
[No Abstract] [Full Text] [Related]
11. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
Muhlestein JB; Grehan S
Drugs R D; 2013 Sep; 13(3):207-13. PubMed ID: 23990357
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
Nguyen E; Coleman CI; Kohn CG; Weeda ER
Int J Cardiol; 2018 Dec; 273():34-38. PubMed ID: 30266352
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
Gutierrez JA; Karwatowska-Prokopczuk E; Murphy SA; Belardinelli L; Farzaneh-Far R; Walker G; Morrow DA; Scirica BM
Clin Cardiol; 2015 Aug; 38(8):469-75. PubMed ID: 26059896
[TBL] [Abstract][Full Text] [Related]
14. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
Ling H; Packard KA; Burns TL; Hilleman DE
Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
Alexopoulos D; Kochiadakis G; Afthonidis D; Barbetseas J; Kelembekoglou P; Limberi S; Spanos A; Triantafyllidis G
Int J Cardiol; 2016 Feb; 205():111-116. PubMed ID: 26730841
[TBL] [Abstract][Full Text] [Related]
16. ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.
Sinha A; Rahman H; Douiri A; Demir OM; De Silva K; Clapp B; Webb I; Gulati A; Pinho P; Dutta U; Ellis H; Shah AM; Chiribiri A; Marber M; Webb AJ; Perera D
Circulation; 2024 Jan; 149(1):36-47. PubMed ID: 37905403
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
18. New Anti-Anginal Drugs: Ranolazine.
Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):14-20. PubMed ID: 25544118
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
Zweiker R; Aichinger J; Metzler B; Lang I; Wallner E; Delle-Karth G
Wien Klin Wochenschr; 2019 Apr; 131(7-8):165-173. PubMed ID: 30963332
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine: effects on ischemic heart.
Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]